Capital Counsel LLC NY Cuts Position in Mettler-Toledo International Inc. (NYSE:MTD)

Capital Counsel LLC NY trimmed its holdings in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 0.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 152,621 shares of the medical instruments supplier's stock after selling 456 shares during the quarter. Mettler-Toledo International comprises 8.0% of Capital Counsel LLC NY's portfolio, making the stock its 9th biggest holding. Capital Counsel LLC NY owned about 0.72% of Mettler-Toledo International worth $186,759,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Barclays PLC raised its position in shares of Mettler-Toledo International by 8.3% during the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier's stock worth $384,822,000 after acquiring an additional 19,609 shares during the last quarter. M&T Bank Corp lifted its position in Mettler-Toledo International by 14.3% during the 3rd quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier's stock valued at $7,387,000 after purchasing an additional 615 shares during the period. Sanctuary Advisors LLC grew its position in shares of Mettler-Toledo International by 44.4% during the 3rd quarter. Sanctuary Advisors LLC now owns 517 shares of the medical instruments supplier's stock worth $775,000 after buying an additional 159 shares during the period. Wilmington Savings Fund Society FSB bought a new position in Mettler-Toledo International in the third quarter valued at approximately $111,000. Finally, Tidal Investments LLC boosted its stake in Mettler-Toledo International by 1,073.6% in the third quarter. Tidal Investments LLC now owns 16,407 shares of the medical instruments supplier's stock valued at $24,606,000 after acquiring an additional 15,009 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Insider Buying and Selling

In other news, insider Gerry Keller sold 600 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the transaction, the insider now directly owns 6 shares in the company, valued at approximately $8,108.04. This represents a 99.01 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Christian Magloth sold 790 shares of the company's stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the transaction, the insider now directly owns 734 shares of the company's stock, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by corporate insiders.

Mettler-Toledo International Stock Up 6.0 %

Shares of Mettler-Toledo International stock traded up $60.06 during trading on Wednesday, reaching $1,063.22. The company's stock had a trading volume of 236,858 shares, compared to its average volume of 141,707. The business's 50-day moving average price is $1,172.72 and its 200-day moving average price is $1,253.42. Mettler-Toledo International Inc. has a 52 week low of $946.69 and a 52 week high of $1,546.93. The firm has a market cap of $22.16 billion, a PE ratio of 26.23, a P/E/G ratio of 3.30 and a beta of 1.28.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Equities analysts predict that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Wall Street Analyst Weigh In

MTD has been the topic of a number of analyst reports. Wells Fargo & Company cut their price target on Mettler-Toledo International from $1,400.00 to $1,125.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 17th. Evercore ISI lifted their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research report on Monday, February 10th. Robert W. Baird reduced their target price on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a report on Tuesday. Finally, Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target for the company in a report on Monday, April 7th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, Mettler-Toledo International presently has an average rating of "Hold" and a consensus target price of $1,304.25.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.